“We deeply value the trust our customers place in Timeline,” said Brian Ray, chief executive officer of Timeline. “We will take every measure necessary to protect that trust, safeguard our customers’ health and root out the bad actors who seek to harm them by trading on our name.”
The ex parte temporary restraining order, entered in Amazentis SA and Timeline Longevity, Inc. v. The Partnerships and Unincorporated Associations Identified on Schedule A, Civil Action No. 1:26-cv-14499-MJJ (D. Mass.), freezes the infringing domain names and any associated payment-processing and online-marketplace accounts.
It also authorizes expedited discovery to identify the individuals or entities behind the scheme and permits Timeline to serve any defendants who remain unidentified through alternative means, given evidence that they have deliberately concealed their identities and locations.
Dozens of illicit sites, more to come
According to the complaint, since at least August 2026, the operators in question have registered a network of look-alike websites that copy the text, images and trademarks displayed on Timeline’s official website to deceive consumers. By the time Timeline filed its complaint, it had identified 35 illicit websites.
In addition to the immediate relief granted, Timeline is seeking permanent injunctive relief, seizure of the infringing websites and associated assets, and an award of damages against the individuals and entities behind the scheme. This includes statutory damages of up to $100,000 per domain name under the Anticybersquatting Consumer Protection Act, 15 U.S.C. § 1117(d), as well as actual damages, attorneys’ fees and all other remedies available under law.
Timeline is asking consumers to purchase its products only on its official site or through authorized retailers or e-tailers and to be cautious of social-media advertisements and unfamiliar domains that resemble the Timeline name.
Although the 35 fraudulent sites initially identified now appear offline, new sites continue to surface. Timeline therefore intends to seek leave to amend the Court’s order to cover any additional sites identified going forward.
Ongoing global enforcement program
This latest legal action is part of what Timeline frames as an ongoing global enforcement program to protect consumers from counterfeit and mislabeled urolithin A products and defend nearly two decades and $50 million of clinical research and intellectual property behind Mitopure.
In July, the same federal court entered judgment against 19 fake online urolithin A supplement sellers, many operating under seemingly legitimate brands.
Independent laboratory testing revealed that these products contained little or, in most cases, no urolithin A.
“Starting in 2023, copycat supplements purporting to contain urolithin A began to appear on Amazon’s e-commerce platform sourced from one or more manufacturers,” the complaint read, noting that these products are sold at much lower prices than Timeline’s proprietary Mitopure-branded urolithin A.
“On information and belief, these fake and falsely labeled urolithin A supplements appeared to have been manufactured by the same companies in the People’s Republic of China; this appears to be true based on the size, color and shape of the packaging and capsules [...], as well as based on other information contained on the Amazon storefronts for each product.”
In its decision, the court permanently enjoined the parties identified from selling urolithin A products and ordered the defendants to pay Timeline damages ranging from $500 to more than $2.7 million each, based on the scale of their sales of fraudulent products. For several defendants, the court tripled the awards as enhanced damages, bringing the total award to more than $5.3 million.
